BY John Hyatt

I worked at MD Anderson for 16 years as a program manager in Employee Health & Wellbeing before retiring in 2015. So, I knew that it was famous for treating rare cancers. But it wasn’t until I was diagnosed with a neuroendocrine tumor in 2018 that I truly appreciated its reputation for excellence.

When I was doing internet research to find the best place for my treatment, MD Anderson was the name that kept popping up. And,...

Neuroendocrine tumor survivor John Hyatt